Department of Urology, Santa Chiara Hospital, Trento.
Arch Ital Urol Androl. 2020 Oct 1;92(3). doi: 10.4081/aiua.2020.3.169.
To evaluate the intermediate perioperative outcomes, rate of complications and functional data after XPS 180-W Greenlight photoselective laser vaporization (PVP) compared with transurethral resection of the prostate (TURP) in a prospective non-randomized single centre study.
We analyzed a prospectively-maintained database collecting data on 100 patients undergoing surgical treatment of BPH (50 consecutive PVP and 50 consecutive TURP). All complications, recorded and graduated according to the Clavien Dindo system and the clinical, operative, perioperative variables were compared. The functional outcomes, International Prostate Symptom Score (IPSS), max flow rate (Qmax) and Prostate Specific Antigen (PSA), were recorded preoperatively and at 1 year of follow up.
Age, prostate volume, use of anticoagulants or antiplatelets, ASA score and operative time were comparable in the two groups. The reduction in the hemoglobin levels (0.46 vs 1.8 g/dL), the catheterization time (1.2 vs 3.2 days), the hospital stay (1.7 vs 3.8 days) and rate of transfused patients (0 vs 8%), were significantly lower for PVP. Transient re-catherization (6 vs 26%) was significantly lower for PVP. The IPSS and Qmax at 1 year showed no significant difference. The rate of repeat TURP/PVP was higher in the TURP group (0 vs 10%). Reduction of PSA, that reflects the major reduction of prostate volume, was statistically greater in PVP group respect TURP group (p = 0.001).
PVP has advantages in terms of perioperative safety and major complications than TURP. Functional outcomes at 1 year of follow-up were comparable.
为了评估 XPS 180-W Greenlight 光选择性激光汽化术(PVP)与经尿道前列腺切除术(TURP)在一个前瞻性非随机单中心研究中的围手术期中期结果、并发症发生率和功能数据。
我们分析了一个前瞻性维护的数据库,其中收集了 100 例接受 BPH 手术治疗的患者的数据(50 例连续 PVP 和 50 例连续 TURP)。根据 Clavien Dindo 系统和临床、手术、围手术期变量记录和分级所有并发症。术前和 1 年随访时记录功能结局、国际前列腺症状评分(IPSS)、最大尿流率(Qmax)和前列腺特异性抗原(PSA)。
两组患者的年龄、前列腺体积、抗凝或抗血小板药物的使用、ASA 评分和手术时间无差异。血红蛋白水平(0.46 对 1.8 g/dL)、导尿管时间(1.2 对 3.2 天)、住院时间(1.7 对 3.8 天)和输血患者比例(0 对 8%)显著降低PVP。TURP 组的一过性再导尿率(6%对 26%)显著较低。1 年时的 IPSS 和 Qmax 无显著差异。TURP 组的重复 TURP/PVP 率较高(0 对 10%)。PSA 降低,反映前列腺体积的主要减少,在 PVP 组比 TURP 组更具统计学意义(p = 0.001)。
与 TURP 相比,PVP 在围手术期安全性和主要并发症方面具有优势。1 年随访时的功能结局相当。